Nur Nicholson
Chief Technical Officer; Chief Technology Officer · 5 filings · Latest: Sep 7, 2026
Apellis Pharmaceuticals, Inc.
Kailera Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
APLS | Nur Nicholson | Chief Technical Officer | Jan 22, 2026 | Sale | $21.77 | 7,725 | $168.1K | 71,118 | |
APLS | Nicholson Nur | — | Jan 22, 2026 | Proposed Sale | $21.77 | 7,725 | $168.1K | — | |
APLS | Nur Nicholson | Chief Technical Officer | Jan 20, 2026 | Sale | $19.79 | 2,203 | $43.6K | 78,843 | |
APLS | Nicholson Nur | — | Jan 20, 2026 | Proposed Sale | $19.79 | 2,203 | $43.6K | — | |
APLS | Nicholson Nur | — | Jan 13, 2026 | Proposed Sale | $22.19 | 2,618 | $58.1K | — | |
APLS | Nicholson Nur | — | Jan 29, 2025 | Proposed Sale | $29.52 | 825 | $24.4K | — | |
APLS | Nicholson Nur | — | Jan 22, 2025 | Proposed Sale | $30.43 | 3,948 | $120.1K | — | |
APLS | Nicholson Nur | — | Jan 17, 2025 | Proposed Sale | $29.96 | 2,145 | $64.3K | — | |
APLS | Nicholson Nur | — | Jan 13, 2025 | Proposed Sale | $28.70 | 2,681 | $76.9K | — |